Based on the availability of autologous tumor specimens, we focused on NUP214 neoepitope-specific CD4+ T-cells obtained from TILs of Pt #19 and JAK1 neoepitope-specific CD4+ T-cells obtained from TILs of Pt #11. This evidence concerns the gene CD4 and neoplasm.